These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30131237)

  • 1. Presence of L701 M mutation in the FKS1 gene of echinocandin-susceptible Candida krusei isolates.
    Lallitto F; Prigitano A; Mangione F; Piralla A; Tamarozzi F; Marone P; Cavanna C
    Diagn Microbiol Infect Dis; 2018 Dec; 92(4):311-314. PubMed ID: 30131237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.
    Desnos-Ollivier M; Bretagne S; Raoux D; Hoinard D; Dromer F; Dannaoui E;
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3092-8. PubMed ID: 18591282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains.
    Castanheira M; Woosley LN; Diekema DJ; Messer SA; Jones RN; Pfaller MA
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2655-9. PubMed ID: 20368396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
    Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
    [No Abstract]   [Full Text] [Related]  

  • 5. Acquired echinocandin resistance in a Candida krusei blood isolate confirmed by mutations in the fks1 gene.
    Prigitano A; Esposito MC; Cogliati M; Pitzurra L; Santamaria C; Tortorano AM
    New Microbiol; 2014 Apr; 37(2):237-40. PubMed ID: 24858652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in candidemia over a 5-year period at Nantes hospital and in vitro susceptibility to three echinocandins by E-test®].
    Thierry G; Morio F; Le Pape P; Gay-Andrieu F; Barre O; Miegeville M
    Pathol Biol (Paris); 2011 Feb; 59(1):52-6. PubMed ID: 20832195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echinocandin failure case due to a previously unreported FKS1 mutation in Candida krusei.
    Jensen RH; Justesen US; Rewes A; Perlin DS; Arendrup MC
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3550-2. PubMed ID: 24687511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.
    Park S; Kelly R; Kahn JN; Robles J; Hsu MJ; Register E; Li W; Vyas V; Fan H; Abruzzo G; Flattery A; Gill C; Chrebet G; Parent SA; Kurtz M; Teppler H; Douglas CM; Perlin DS
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3264-73. PubMed ID: 16048935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
    J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterisation of Candida auris isolates from immunocompromised patients in a tertiary-care hospital in Kuwait reveals a novel mutation in FKS1 conferring reduced susceptibility to echinocandins.
    Asadzadeh M; Mokaddas E; Ahmad S; Abdullah AA; de Groot T; Meis JF; Shetty SA
    Mycoses; 2022 Mar; 65(3):331-343. PubMed ID: 34953089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of Candida parapsilosis FKS1 and FKS2 mutations in reduced echinocandin susceptibility.
    Martí-Carrizosa M; Sánchez-Reus F; March F; Cantón E; Coll P
    Antimicrob Agents Chemother; 2015; 59(6):3570-3. PubMed ID: 25779577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment.
    Lackner M; Tscherner M; Schaller M; Kuchler K; Mair C; Sartori B; Istel F; Arendrup MC; Lass-Flörl C
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3626-35. PubMed ID: 24733467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyr.
    Staab JF; Neofytos D; Rhee P; Jiménez-Ortigosa C; Zhang SX; Perlin DS; Marr KA
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5421-7. PubMed ID: 24982083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase.
    Kahn JN; Garcia-Effron G; Hsu MJ; Park S; Marr KA; Perlin DS
    Antimicrob Agents Chemother; 2007 May; 51(5):1876-8. PubMed ID: 17325225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007-2014.
    Lovero G; Borghi E; Balbino S; Cirasola D; De Giglio O; Perdoni F; Caggiano G; Morace G; Montagna MT
    PLoS One; 2016; 11(2):e0150218. PubMed ID: 26919294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
    Orasch C; Marchetti O; Garbino J; Schrenzel J; Zimmerli S; Mühlethaler K; Pfyffer G; Ruef C; Fehr J; Zbinden R; Calandra T; Bille J;
    Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida lusitaniae MICs to the echinocandins are elevated but FKS-mediated resistance is rare.
    Lockhart SR; Pham CD; Kuykendall RJ; Bolden CB; Cleveland AA
    Diagn Microbiol Infect Dis; 2016 Jan; 84(1):52-54. PubMed ID: 26429293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong
    Schell WA; Jones AM; Garvey EP; Hoekstra WJ; Schotzinger RJ; Alexander BD
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata.
    Shields RK; Nguyen MH; Press EG; Kwa AL; Cheng S; Du C; Clancy CJ
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4862-9. PubMed ID: 22751546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.